[1] YU H,GUO Z,XING W,et al.Bile culture and susceptibility testing of malignant biliary obstruction via PTBD[J].Cardiovasc Intervent Radiol,2012,35(5):1136.
[2] 于海鹏.恶性梗阻性黄疸继发胆道感染病原学研究及多因素分析[D].天津:天津医科大学,2011.
[3] 郭秀英,郭志,邢文阁,等.301例恶性梗阻性黄疸胆汁细菌培养与药物敏感性的临床研究[J].中华检验医学杂志,2009,32(10):1176.
[4] 沈勇.恶性梗阻性黄疸患者胆汁细菌检出的临床分析[D].上海:复旦大学,2010.
[5] XU C,HUANG XE,WANG SX,et al.Comparision of infection between internal-external and external percutaneous transhepatic biliary drainage in treating patients with malignant obstructive jaundice[J].Asian Pac J Cancer Prev,2015,16(6):2543.
[6] BROWN KT,COVEY AM.Management of malignant biliary obstruction[J].Tech Vasc Interv Radiol,2008,11(1):43.
[7] 郭春霞,高社干.C反应蛋白和肿瘤的关系[J].中国社区医师,2014,30(29):111.
[8] 王卫东,陈小伍,何威,等.PTCD联合鼻肠营养管行外引流胆汁回输及肠内营养对内脏蛋白及肝功能的影响[J].南方医科大学学报,2010,30(1):146.
[9] 黄志强.黄志强胆道外科手术学[M].北京:人民军医出版社,2010:69.
[10] TSUYUGUCHI T,TAKADA T,MIYAZAKI M,et al.Stenting and interventional radiology for obstructive jaundic in patients with unresectable biliary tract carcinomas[J].J Hepatobiliary Pancreat Surg,2008,15(1):69.
[11] 刘凌云,杨定华,彭民浩.恶性梗阻性黄疸患者外周血CD4+CD25+调节性T细胞的变化及意义[J].实用医学杂志,2011,27(5):800.
[12] 吴伯文.实用肝脏外科学[M].北京:人民军医出版社,2009:98.
[13] 王书智,时之梅,陆蕊,等.不同类型梗阻性黄疸胆汁细菌生长分析[J].中华医院感染学杂志,2009,19(22):3130.
[14] 王敏,孟庆玲,林洁,等.胆道恶性梗阻胆汁病原菌与敏感抗生素及有关因素分析[J].中国微创外科杂志,2011,11(12):1116.